Aadi Biosciences Newsroom

Aadi Bioscience Price Target Cut to $1.75/Share From $5.00 by Piper Sandler

Dow JonesAug 27, 2024 22:57

Piper Sandler Downgrades Aadi Biosciences(AADI.US) to Hold Rating, Cuts Target Price to $1.75

Futu NewsAug 27, 2024 17:32

Aadi Bioscience Analyst Ratings

BenzingaAug 21, 2024 20:22

TD Cowen Maintains Aadi Biosciences(AADI.US) With Hold Rating

Futu NewsAug 21, 2024 19:33

H.C. Wainwright Maintains Aadi Biosciences(AADI.US) With Hold Rating

Futu NewsAug 21, 2024 18:31

TD Cowen Downgrades Aadi Biosciences(AADI.US) to Hold Rating

Futu NewsAug 21, 2024 08:31

Aadi Bioscience Analyst Ratings

BenzingaMay 14, 2024 18:35

Aadi Bioscience Analyst Ratings

BenzingaDec 15, 2023 19:31

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $36

BenzingaNov 14, 2023 07:15

Aadi Bioscience Analyst Ratings

BenzingaNov 14, 2023 07:11

HC Wainwright & Co. Reiterates Buy on Aadi Bioscience, Maintains $45 Price Target

BenzingaAug 10, 2023 19:41

Aadi Bioscience Analyst Ratings

BenzingaAug 10, 2023 19:40

HC Wainwright & Co. Reiterates Buy on Aadi Bioscience, Maintains $45 Price Target

BenzingaMay 17, 2023 22:11

HC Wainwright Adjusts Price Target on Aadi Bioscience to $45 From $48, Maintains Buy Rating

MT NewswiresMar 29, 2023 19:24

HC Wainwright & Co. Maintains Buy on Aadi Bioscience, Lowers Price Target to $45

BenzingaMar 29, 2023 18:15